Every day, patients are hospitalized with a factor Xa (FXa) inhibitor-related acute major bleed. For those patients, every moment matters. Uncover the latest information on managing patients with FXa inhibitor-related acute major bleeding in this live discussion.
The burden of life-threatening bleeds related to FXa Inhibitors
The rationale behind the reversal of anti-FXa activity
Clinical trials evaluating the efficacy and safety of FXa inhibitor reversal
Real world studies evaluating FXa inhibitor reversals
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our